Skip to content Skip to search

Republish This Story

* Please read before republishing *

We’re happy to make this story available to republish for free under an Attribution-NonCommercial-NoDerivatives Creative Commons license as long as you follow our republishing guidelines, which require that you credit The 19th and retain our pixel. See our full guidelines for more information.

To republish, simply copy the HTML at right, which includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to The 19th. Have questions? Please email [email protected].

— The Editors

Loading...

Modal Gallery

/

Menu

  • Our Mission
  • Our Team
  • Latest Stories
  • Search
  • Upcoming Events
  • Contact Us
  • Newsletter
  • Donate
  • Work With Us
  • Fellowships
    • From the Collection

      Changing Child Care

      Illustration of a woman feeding a baby a bottle
      • The full PUMP Act is now in effect. Here’s what it does for lactating parents.

        Chabeli Carrazana · April 28
      • 1 in 4 parents report being fired for work interruptions due to child care breakdowns

        Chabeli Carrazana · February 2
      • Washington, D.C., offers financial relief to local child care workers

        Orion Rummler · September 20
    • From the Collection

      Next-Gen GOP

      Illustration of a woman riding an elephant
      • Mayra Flores’ victory set a record for women in Congress. It also reflects the growing visibility of Republican Latinas

        Candice Norwood · June 21
      • A banner year for Republican women

        Amanda Becker · November 11
      • Republican women could double representation in the U.S. House

        Amanda Becker · November 4
    • From the Collection

      On The Rise

      Illustration of three women marching
      • This Delaware candidate could be the first transgender member of Congress

        Orion Rummler · June 26
      • Can Cheri Beasley build a winning coalition in North Carolina?

        Candice Norwood · October 11
      • Los Angeles has never elected a woman mayor. Karen Bass hopes to change that.

        Nadra Nittle · September 8
    • From the Collection

      Pandemic Within a Pandemic

      Illustration of four people marching for Black Lives Matter with coronavirus as the backdrop
      • Some LGBTQ+ people worry that the COVID-19 vaccine will affect HIV medication. It won’t.

        Orion Rummler · November 23
      • Why are more men dying from COVID? It’s a complicated story of nature vs. nurture, researchers say

        Mariel Padilla · September 22
      • Few incarcerated women were released during COVID. The ones who remain have struggled.

        Candice Norwood · August 17
    • From the Collection

      Portraits of a Pandemic

      Illustration of a woman wearing a mask and holding up the coronavirus
      • For family caregivers, COVID is a mental health crisis in the making

        Shefali Luthra · October 8
      • A new database tracks COVID-19’s effects on sex and gender

        Shefali Luthra · September 15
      • Pregnant in a pandemic: The 'perfect storm for a crisis'

        Shefali Luthra · August 25
    • From the Collection

      The 19th Explains

      People walking from many articles to one article where they can get the context they need on an issue.
      • The 19th Explains: What are 'late-term abortions' — and why are politicians talking about them? 

        Mel Leonor Barclay, Shefali Luthra · August 21
      • The 19th Explains: Why child marriage is still legal in 80% of U.S. states

        Mariel Padilla · July 5
      • The 19th Explains: The Supreme Court’s decision in the LGBTQ+ 303 Creative case

        Kate Sosin · June 30
    • From the Collection

      The Electability Myth

      Illustration of three women speaking at podiums
      • Mayra Flores’ victory set a record for women in Congress. It also reflects the growing visibility of Republican Latinas

        Candice Norwood · June 21
      • Stepping in after tragedy: How political wives became widow lawmakers

        Mariel Padilla · May 24
      • Do term limits help women candidates? New York could be a new testing ground

        Barbara Rodriguez · January 11
    • From the Collection

      The Impact of Aging

      A number of older people walking down a path of information.
      • From ballroom dancing to bloodshed, the older AAPI community grapples with gun control

        Nadra Nittle, Mariel Padilla · January 27
      • 'I'm planning on working until the day I die': Older women voters are worried about the future

        Mariel Padilla · June 3
      • Climate change is forcing care workers to act as first responders

        Jessica Kutz · May 31
    • From the Collection

      The State of Our Nation

      • States passing abortion bans reflect what only a small minority of their constituents actually want

        Jasmine Mithani · October 24
    • From the Collection

      Voting Rights

      A series of hands reaching for ballots.
      • Voting organizers are breathing ‘a deep sigh of relief’ over Supreme Court rulings on elections — for now

        Barbara Rodriguez · July 6
      • Ranked-choice voting is gaining momentum. So are efforts to stop it.

        Barbara Rodriguez · April 24
      • Connecticut voters approved early voting. Here’s how their new secretary of state wants to make it happen.

        Barbara Rodriguez · February 13

    View all collections

  • Explore by Topic

    • 19th Polling
    • Abortion
    • Business & Economy
    • Caregiving
    • Coronavirus
    • Education
    • Election 2020
    • Election 2022
    • Election 2024
    • Environment & Climate
    • Health
    • Immigration
    • Inside The 19th
    • Justice
    • LGBTQ+
    • Military
    • Politics
    • Press Release
    • Race
    • Sports
    • Technology

    View All Topics

Home
  • Our Mission
  • Our Team
  • Latest Stories
  • Search
  • Upcoming Events
  • Contact Us
  • Newsletter
  • Donate
  • Work With Us
  • Fellowships

We’re an independent, nonprofit newsroom reporting on gender, politics and policy. Read our story.

The 19th News(letter)

News that represents you, in your inbox every weekday.

You have been subscribed!

Please complete the following CAPTCHA to be confirmed. If you have any difficulty, contact [email protected] for help.

Submitting...

Uh-oh! Something went wrong. Please email [email protected] to subscribe.

Become a member

The 19th thanks our sponsors. Become one.

packages of Mifepristone tablets are displayed at a family planning clinic on April 13, 2023 in Rockville, Maryland.
Packages of Mifepristone tablets are displayed at a family planning clinic on April 13, 2023 in Rockville, Maryland. (Anna Moneymaker/Getty Images)

Abortion

An abortion pill distributor reportedly won’t supply the drug to pharmacies in 31 states. House Democrats want answers.

A letter led by the House Democratic Women’s Caucus shared first with The 19th asks AmerisourceBergen for the full list of states where it reportedly won’t distribute mifepristone to pharmacies.

Grace Panetta

Political reporter

Grace Panetta

Published

2023-05-11 10:00
10:00
May 11, 2023
am

Share

  • Twitter
  • Facebook
  • Email

Your trusted source for contextualizing abortion & politics news. Sign up for our daily newsletter.

Over 60 House Democrats are looking for answers from AmerisourceBergen following reports that the company would not distribute the abortion pill to pharmacies in up to 31 states. AmerisourceBergen is the sole U.S. distributor of Mifeprex, the brand name for mifepristone, a drug used in a two-step regimen to terminate pregnancies and manage miscarriages.

In a letter led by members of the House Democratic Women’s Caucus and shared first with The 19th, a group of House Democrats said they were “concerned” by the reports. The Pennsylvania-based company’s decisions, they noted, “could be the determining factor” in patients being able to access the drug at pharmacies. 

The 19th thanks our sponsors. Become one.

The letter asks Steven H. Collis, the company’s president and CEO, to provide “the full list of states and jurisdictions” where the company intends not to distribute Mifeprex and “clearly outline the determination process and the rationale used to develop that list.”

“If you are unable or unwilling to provide a list,” the letter continues, “we request that you provide clear steps on how Members of Congress can access this information about their state from AmerisourceBergen.”

The lead signatories of the letter were House Democratic Women’s Caucus Chair Rep. Lois Frankel of Florida; vice chairs Reps. Teresa Leger Fernández of New Mexico and Nikema Williams of Georgia; policy task force co-chair Rep. Kathy Manning of North Carolina; and Rep. Anna Eshoo of California, ranking member of the Health Subcommittee on the House Energy and Commerce Committee. 

Rep. Nikema Williams is seen on the House steps of the Capitol.
Rep. Nikema Williams is seen on the House steps of the Capitol. (Tom Williams/CQ-Roll Call/Getty Images)

“This one company could be a determining factor in whether women can access medication abortion, so our ask here is simple: lawmakers want to see their list of states where they do not plan to supply this medication to pharmacies, so we can better understand the impact on our constituents. This is just too important to stay silent,” Frankel told The 19th.

In January, the Food and Drug Administration (FDA) moved to allow retail pharmacies to dispense mifepristone for the first time. That guidance was met with swift resistance and threats of legal action by Republican attorneys general. Walgreens, the nation’s second-largest retail pharmacy chain, sparked widespread backlash by assuring 21 Republican AGs that it wouldn’t dispense the drug at pharmacies in their states. 

Vox then reported that AmerisourceBergen had provided its corporate clients with a list, based on data from the Guttmacher Institute, a think tank that conducts research on abortion policy, of 31 states where it wouldn’t distribute Mifeprex to retail pharmacies. It’s not publicly known which states are on the reported list, though Politico reported that Nevada is among them. The company’s status as the drug’s sole distributor in the United States gives it immense power in determining access to medication abortion. 

An AmerisourceBergen spokesperson pointed The 19th to a March 15 statement in which the company said it’s distributing the drug to eligible physicians and providers in all 50 states and “certified retail sites of care in states where it is consistent with the law.” The company did not clarify where it would or would not distribute the drug at pharmacies.

  • More abortion pill coverage
    Anti-abortion activists gather in the snow at the Colorado Capitol on April 4, 2023, to protest a package of reproductive health bills.
  • Colorado becomes the first state to ban controversial abortion pill reversals
  • Supreme Court decision allows abortion pill to continue being distributed by mail
  • Senators ask mifepristone manufacturer to list miscarriage as a use for abortion pill

“AmerisourceBergen does not and should not make clinical decisions or values-based judgments on which FDA-approved products it distributes,” the statement added. 

Democratic Sen. Tammy Duckworth of Illinois previously asked the Federal Trade Commission, the nation’s top consumer protection watchdog, to investigate AmerisourceBergen’s handling of medication abortion distribution. She wrote in a letter to Chair Lina Khan that the company “may be using broader political disagreements and active legal debates as pretextual cover and justification for engaging in anticompetitive, unfair and deceptive practices.” 

The Department of Justice is currently suing AmerisourceBergen in an unrelated suit brought in December accusing the company of fueling the opioid epidemic by failing to report suspicious orders of controlled substances from pharmacies. The company refuted the DOJ’s allegations and said their case was built on “cherry-picked” examples.

Mifepristone is recognized by both the FDA and the World Health Organization as a safe and effective medication to terminate a pregnancy when used with misoprostol, the other drug in the two-pill regimen. Medication abortion and telemedicine have risen in popularity in the United States and become especially crucial in the wake of the Supreme Court’s overturning of Roe v. Wade, which allowed states to ban abortion entirely. Misopristol-only abortions, while safe, are less effective and can carry more adverse side effects.

The newsletter for the new electorate, delivered to your inbox every other week

You have been subscribed!

Please complete the following CAPTCHA to be confirmed. If you have any difficulty, contact [email protected] for help.

Submitting…

Uh-oh! Something went wrong. Please email [email protected] to subscribe.

Mifepristone has been the subject of high-profile legal battles in the past several months, spurring widespread confusion and potentially uneven access to the drug. One lawsuit brought by a group of anti-abortion doctors seeking to revoke the drug’s initial FDA approval issued in 2000 ended up in the U.S. Supreme Court. 

The high court blocked a ruling from a federal district court judge in Texas that would’ve stripped the FDA’s approval of the drug. It also halted a decision from the 5th U.S. Circuit Court of Appeals that would have allowed the drug to remain approved but with certain restrictions, including three required in-person visits and a ban on providers mailing the drug. 

The Supreme Court’s intervention in blocking both rulings means the drug remains widely legal and accessible, including by mail for now, though some Republican-dominated states are set to ban telemedicine abortion in new abortion restriction bills.

Disclosure: AmerisourceBergen has been a corporate sponsor of The 19th.

Share

  • Twitter
  • Facebook
  • Email

The 19th News(letter)

News that represents you, in your inbox every weekday.

You have been subscribed!

Please complete the following CAPTCHA to be confirmed. If you have any difficulty, contact [email protected] for help.

Submitting...

Uh-oh! Something went wrong. Please email [email protected] to subscribe.

Become a member

Up Next

Lashrecse Aird delivers a speech at the Virginia Capitol in March 2020, in Richmond, Virginia.

Abortion

Virginia could be key to abortion access in the South. Its laws could hinge on this Democratic primary.

Lashrecse Aird is challenging incumbent state Sen. Joe Morrissey, a disbarred defense attorney who has faced a number of personal scandals and who has not been clear on what, if any, restrictions he would support or oppose.

Read the Story

The 19th
The 19th is a 501(c)(3) tax-exempt organization. Our stories are free to republish in accordance with these guidelines.

  • Donate
  • Newsletter
  • Events
  • Search
  • Jobs
  • Fellowships
  • Contact Us
  • About Us
  • Community Guidelines
  • Membership
  • Membership FAQ
  • Ways to Give
  • Sponsorship
  • Privacy
  • Twitter
  • Facebook
  • Instagram